115 related articles for article (PubMed ID: 34052342)
1. Hippocampal sparing in patients receiving radiosurgery for ≥25 brain metastases.
Kavi A; Gurewitz J; Benjamin CG; Silverman JS; Bernstein K; Mureb M; Oh C; Sulman EP; Donahue B; Kondziolka D
Radiother Oncol; 2021 Aug; 161():65-71. PubMed ID: 34052342
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and TomoTherapy stereotactic radiosurgery.
Zhang I; Antone J; Li J; Saha S; Riegel AC; Vijeh L; Lauritano J; Marrero M; Salas S; Schulder M; Zinkin H; Goenka A; Knisely J
Pract Radiat Oncol; 2017; 7(3):183-189. PubMed ID: 28477798
[TBL] [Abstract][Full Text] [Related]
3. Single-Fraction Stereotactic Radiosurgery Versus Hippocampal-Avoidance Whole Brain Radiation Therapy for Patients With 10 to 30 Brain Metastases: A Dosimetric Analysis.
Nguyen TK; Sahgal A; Detsky J; Soliman H; Myrehaug S; Tseng CL; Husain ZA; Carty A; Das S; Yang V; Lee Y; Sarfehnia A; Chugh BP; Yeboah C; Ruschin M
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):394-399. PubMed ID: 31283978
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal dose from stereotactic radiosurgery for 4 to 10 brain metastases: Risk factors, feasibility of dose reduction via re-optimization, and patient outcomes.
Birer SR; Olson AC; Adamson J; Hood R; Susen M; Kim G; Salama JK; Kirkpatrick JP
Med Dosim; 2017 Winter; 42(4):310-316. PubMed ID: 28760560
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of hippocampal avoidance whole brain radiation in patients with hippocampal involvement: Data from a prospective study.
Lee G; Besse L; Lamba N; Hancox C; Usta I; Hacker F; Catalano P; Brown PD; Tanguturi S; Pashtan I; Phillips J; Haas-Kogan D; Alexander B; Cagney D; Aizer A
Med Dosim; 2021 Spring; 46(1):21-28. PubMed ID: 32778521
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal Dosimetry and the Necessity of Hippocampal-Sparing in Gamma Knife Stereotactic Radiosurgery for Extensive Brain Metastases.
Riina MD; Stambaugh CK; Huber KE
Adv Radiat Oncol; 2020; 5(2):180-188. PubMed ID: 32280817
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal Sparing Whole Brain Radiotherapy and Integrated Simultaneous Boost vs Stereotactic Radiosurgery Boost: A Comparative Dosimetric Planning Study.
Cheah SK; Matthews T; Teh BS
Asian Pac J Cancer Prev; 2016; 17(9):4233-4235. PubMed ID: 27797223
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery optimization with hippocampal-sparing in patients treated for brain metastases.
Burgess L; Nair V; Gratton J; Doody J; Chang L; Malone S
Phys Imaging Radiat Oncol; 2021 Jan; 17():106-110. PubMed ID: 33898788
[TBL] [Abstract][Full Text] [Related]
9. The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.
Varlotto JM; Flickinger JC; Niranjan A; Bhatnagar A; Kondziolka D; Lunsford LD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1125-32. PubMed ID: 15990018
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal sparing in stereotactic radiotherapy for brain metastases: To contour or not contour the hippocampus?
Di Carlo C; Trignani M; Caravatta L; Vinciguerra A; Augurio A; Perrotti F; Di Tommaso M; Nuzzo M; Giancaterino S; Falco MD; Genovesi D
Cancer Radiother; 2018 Apr; 22(2):120-125. PubMed ID: 29576492
[TBL] [Abstract][Full Text] [Related]
11. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
[TBL] [Abstract][Full Text] [Related]
12. Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases.
Bowden GN; Kim JO; Faramand A; Fallon K; Flickinger J; Lunsford LD
J Neurosurg; 2020 May; 134(5):1430-1434. PubMed ID: 32384280
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal Dose With Radiosurgery for Multiple Intracranial Targets: The Rationale for Proactive Beam Shaping.
Chang JS; Ma L; Barani IJ; McDermott MW; Sneed PK; Larson DA
Technol Cancer Res Treat; 2016 Aug; 15(4):555-9. PubMed ID: 26113558
[TBL] [Abstract][Full Text] [Related]
14. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts.
Prokic V; Wiedenmann N; Fels F; Schmucker M; Nieder C; Grosu AL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):264-70. PubMed ID: 22516808
[TBL] [Abstract][Full Text] [Related]
15. Treatment of brain metastases of renal cell cancer with combined hypofractionated stereotactic radiotherapy and whole brain radiotherapy with hippocampal sparing.
Vrána D; Študentová H; Matzenauer M; Vlachová Z; Cwiertka K; Gremlica D; Kalita O
Oncol Lett; 2016 Jun; 11(6):3777-3781. PubMed ID: 27313693
[TBL] [Abstract][Full Text] [Related]
16. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic Radiosurgery to More Than 10 Brain Metastases: Evidence to Support the Role of Radiosurgery for Ideal Hippocampal Sparing in the Treatment of Multiple Brain Metastases.
Susko MS; Garcia MA; Ma L; Nakamura JL; Raleigh DR; Fogh S; Theodosopoulos P; McDermott M; Sneed PK; Braunstein SE
World Neurosurg; 2020 Mar; 135():e174-e180. PubMed ID: 31785436
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
[TBL] [Abstract][Full Text] [Related]
19. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
20. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
